- Home
- LXEH vs NDRA Comparison
LXEH vs NDRA Comparison
Compare LXEH & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEH
- NDRA
- Stock Information
- Founded
- LXEH 2001
- NDRA 2007
- Country
- LXEH China
- NDRA United States
- Employees
- LXEH N/A
- NDRA N/A
- Industry
- LXEH Other Consumer Services
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LXEH Real Estate
- NDRA Health Care
- Exchange
- LXEH Nasdaq
- NDRA Nasdaq
- Market Cap
- LXEH 4.7M
- NDRA 5.1M
- IPO Year
- LXEH 2020
- NDRA 2017
- Fundamental
- Price
- LXEH $2.20
- NDRA $4.54
- Analyst Decision
- LXEH
- NDRA Strong Buy
- Analyst Count
- LXEH 0
- NDRA 1
- Target Price
- LXEH N/A
- NDRA $14,000.00
- AVG Volume (30 Days)
- LXEH 32.0K
- NDRA 709.8K
- Earning Date
- LXEH 09-27-2024
- NDRA 11-15-2024
- Dividend Yield
- LXEH N/A
- NDRA N/A
- EPS Growth
- LXEH N/A
- NDRA N/A
- EPS
- LXEH N/A
- NDRA N/A
- Revenue
- LXEH $5,628,870.00
- NDRA N/A
- Revenue This Year
- LXEH N/A
- NDRA N/A
- Revenue Next Year
- LXEH N/A
- NDRA N/A
- P/E Ratio
- LXEH N/A
- NDRA N/A
- Revenue Growth
- LXEH N/A
- NDRA N/A
- 52 Week Low
- LXEH $2.11
- NDRA $4.41
- 52 Week High
- LXEH $65.06
- NDRA $4,882.50
- Technical
- Relative Strength Index (RSI)
- LXEH 37.83
- NDRA 31.46
- Support Level
- LXEH $2.80
- NDRA $5.23
- Resistance Level
- LXEH $2.75
- NDRA $8.80
- Average True Range (ATR)
- LXEH 0.23
- NDRA 1.58
- MACD
- LXEH -0.07
- NDRA -0.06
- Stochastic Oscillator
- LXEH 4.58
- NDRA 1.73
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.